With effect from 01 January 2018
GlaxoSmithkline Consumer Healthcare announced that Horlicks Limited has nominated Saluja as a Nominee Director on the Board of the Company with effect from 01 January 2018 in place of Manoj Kumar who has decided to pursue his personal interests outside of the Company.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
